| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide
|
Berger, Kerstin
|
|
|
147 |
1 |
p. 253-262
|
artikel
|
| 2 |
Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria
|
Kim, Jin Cheon
|
|
|
147 |
1 |
p. 117-128
|
artikel
|
| 3 |
A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis
|
Choi, Wonyoung
|
|
|
147 |
1 |
p. 213-222
|
artikel
|
| 4 |
An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning
|
Ren, En-hui
|
|
|
147 |
1 |
p. 153-165
|
artikel
|
| 5 |
A note from the editors
|
Hoeffken, Klaus
|
|
|
147 |
1 |
p. 1
|
artikel
|
| 6 |
Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis
|
Pervaiz, Asim
|
|
|
147 |
1 |
p. 73-91
|
artikel
|
| 7 |
A prediction model to evaluate the pretest risk of malignancy in solitary pulmonary nodules: evidence from a large Chinese southwestern population
|
Wu, Zuohong
|
|
|
147 |
1 |
p. 275-285
|
artikel
|
| 8 |
Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses
|
Jiang, Yu
|
|
|
147 |
1 |
p. 139-151
|
artikel
|
| 9 |
B-MYB—p53-related relevant regulator for the progression of clear cell renal cell carcinoma
|
Nientiedt, M.
|
|
|
147 |
1 |
p. 129-138
|
artikel
|
| 10 |
BRAFV600E, hypothyroidism, and human relaxin in thyroid carcinogenesis
|
Hernandez, Brenda Y.
|
|
|
147 |
1 |
p. 183-194
|
artikel
|
| 11 |
Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system
|
Hirsch, Daniela
|
|
|
147 |
1 |
p. 263-273
|
artikel
|
| 12 |
Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
|
Wiegel, Thomas
|
|
|
147 |
1 |
p. 243-244
|
artikel
|
| 13 |
Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression
|
Masuda, Ken
|
|
|
147 |
1 |
p. 245-251
|
artikel
|
| 14 |
Elevated ZBTB7A expression in the tumor invasive front correlates with more tumor budding formation in gastric adenocarcinoma
|
Sun, Yujing
|
|
|
147 |
1 |
p. 105-115
|
artikel
|
| 15 |
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers
|
Hose, Dorothea
|
|
|
147 |
1 |
p. 205-212
|
artikel
|
| 16 |
Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B
|
Yang, Yinan
|
|
|
147 |
1 |
p. 93-103
|
artikel
|
| 17 |
High Wilms’ tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m6A methylation of MYC mRNA
|
Naren, Duolan
|
|
|
147 |
1 |
p. 33-47
|
artikel
|
| 18 |
MAPK signaling pathway-targeted marine compounds in cancer therapy
|
Wei, Jiaen
|
|
|
147 |
1 |
p. 3-22
|
artikel
|
| 19 |
Mendelian randomization study indicates lack of causal relationship between physical activity and lung cancer
|
Xian, Wei
|
|
|
147 |
1 |
p. 177-181
|
artikel
|
| 20 |
MET canonical transcript expression is a predictive biomarker for chemo-sensitivity to MET-inhibitors in hepatocellular carcinoma cell lines
|
Rashed, Wafaa M.
|
|
|
147 |
1 |
p. 167-175
|
artikel
|
| 21 |
Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study
|
Kashiwabara, Kosuke
|
|
|
147 |
1 |
p. 287-293
|
artikel
|
| 22 |
Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors
|
Burenina, Olga Y.
|
|
|
147 |
1 |
p. 49-59
|
artikel
|
| 23 |
Peripheral blood T lymphocytosis in thymoma: an insight into immunobiology
|
Mishra, Shruti
|
|
|
147 |
1 |
p. 295-301
|
artikel
|
| 24 |
Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres
|
Albrecht, Katharina Carolin
|
|
|
147 |
1 |
p. 23-32
|
artikel
|
| 25 |
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
|
Wiegel, Thomas
|
|
|
147 |
1 |
p. 235-242
|
artikel
|
| 26 |
Reviewer Acknowledgements 2020
|
|
|
|
147 |
1 |
p. 303-321
|
artikel
|
| 27 |
Risk of lung cancer and renin–angiotensin blockade: a concise review
|
Rachow, Tobias
|
|
|
147 |
1 |
p. 195-204
|
artikel
|
| 28 |
Stem signatures associated antibodies yield early diagnosis and precise prognosis predication of patients with non-small cell lung cancer
|
Chen, Si-Si
|
|
|
147 |
1 |
p. 223-233
|
artikel
|
| 29 |
Stratification of Stage III colon cancer may identify a patient group not requiring adjuvant chemotherapy
|
Malik, Yasir G.
|
|
|
147 |
1 |
p. 61-71
|
artikel
|
Tijdschrift beschrijving